Records containing: Leukemia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-20
The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial
CLINICAL_TRIALS study record update · 2026-02-20
Expanded Access Protocol Using CD3+/CD19+ Depleted Unrelated Donor or Related Donor Peripheral Stem Cells
CLINICAL_TRIALS study record update · 2026-02-19
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
CLINICAL_TRIALS study record update · 2026-02-18
A Phase I Study of Venetoclax Combined With Vyxeos (CPX-351) for Children, Adolescents and Young Adults With Relapsed or Refractory Acute Leukemia
CLINICAL_TRIALS study record update · 2026-02-18
Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-07: A Phase 1/2 Study of CD22-Specific CAR T Cells for CD22+ Leukemia or Lymphoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-02-18
A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies
CLINICAL_TRIALS study record update · 2026-02-12
National Longitudinal Cohort of Hematological Diseases (NICHE)
CLINICAL_TRIALS study record update · 2026-02-12
A Family-based Intervention Approach to Address Weight Gain in Pediatric Leukemia Survivors
CLINICAL_TRIALS study record update · 2026-02-12
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
CLINICAL_TRIALS study record update · 2026-02-11
A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab
CLINICAL_TRIALS study record update · 2026-02-11
A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine in Patients Post Cellular Therapy for Hematological Malignancies
CLINICAL_TRIALS study record update · 2026-02-10
Phase I/Ib Clinical Trial of Autologous CD22 Chimeric Antigen Receptor (CAR) T Cells Following Commercial CD19 CAR T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
CLINICAL_TRIALS study record update · 2026-02-09
Cardiovascular Effects of Chimeric Antigen Receptor T-Cell (CART Cell) Therapy: An Observational Prospective Study
CLINICAL_TRIALS study record update · 2026-02-06
Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
CLINICAL_TRIALS study record update · 2026-02-05
Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
CLINICAL_TRIALS study record update · 2026-02-05
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
CLINICAL_TRIALS study record update · 2026-02-05
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
CLINICAL_TRIALS study record update · 2026-02-03
A Prospective, Single-Arm, Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
CLINICAL_TRIALS study record update · 2026-02-02
Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies
CLINICAL_TRIALS study record update · 2026-01-28
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
CLINICAL_TRIALS study record update · 2026-01-27
Combination of Lenalidomide and Rituximab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) as Initial Treatment or Subsequent Therapy
CLINICAL_TRIALS study record update · 2026-01-23
INSPIRE-AYA: A Multicenter Interactive Survivorship Program to Improve Healthcare Resources for Adolescent and Young Adult (AYA) Cancer Survivors
CLINICAL_TRIALS study record update · 2026-01-23
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
CLINICAL_TRIALS study record update · 2026-01-22
Integrated Cancer Repository for Cancer Research
CLINICAL_TRIALS study record update · 2026-01-21
A Phase 1/2 Study of the Menin Inhibitor Revumenib With the CELMod Mezigdomide in Relapsed/Refractory KMT2A-rearanged, NPM1-mutant, and NUP98-rearranged Acute Leukemias